|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-6-29
|
|
pubmed:abstractText |
Existing drug therapies for paroxysmal supraventricular tachycardia (PSVT) have potentially serious adverse effects. Dofetilide, a pure class III antiarrhythmic agent, may offer an effective and safe alternative for treating PSVT. This study compared the efficacy and safety of dofetilide with that of propafenone and placebo in the prevention of PSVT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0002-8703
|
|
pubmed:author |
pubmed-author:DroszczWW,
pubmed-author:GraffOO,
pubmed-author:Kawecka-JaszczKK,
pubmed-author:KozlowskiJ WJW,
pubmed-author:Krzeminska-PakulaMM,
pubmed-author:KulakowskiPP,
pubmed-author:MalolepszyJJ,
pubmed-author:RuzylloWW,
pubmed-author:SwiateckaGG,
pubmed-author:SzechinskiJJ,
pubmed-author:TenderaMM,
pubmed-author:Wnuk-WojnarA MAM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
142
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11431663-Administration, Oral,
pubmed-meshheading:11431663-Aged,
pubmed-meshheading:11431663-Anti-Arrhythmia Agents,
pubmed-meshheading:11431663-Double-Blind Method,
pubmed-meshheading:11431663-Female,
pubmed-meshheading:11431663-Humans,
pubmed-meshheading:11431663-Male,
pubmed-meshheading:11431663-Middle Aged,
pubmed-meshheading:11431663-Phenethylamines,
pubmed-meshheading:11431663-Propafenone,
pubmed-meshheading:11431663-Proportional Hazards Models,
pubmed-meshheading:11431663-Sulfonamides,
pubmed-meshheading:11431663-Survival Analysis,
pubmed-meshheading:11431663-Tachycardia, Supraventricular,
pubmed-meshheading:11431663-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.
|
|
pubmed:affiliation |
3rd Department of Cardiology, Silesian Medical Academy, Katowice, Poland. mtendera@katowice.computerland.pl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
